Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2020-06-01
2020-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characteristics of COVID-19 Infection Among PREGnant Women
NCT04398264
Evaluating Clinical Parameters of COVID-19 in Pregnancy
NCT04470583
Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns
NCT04355234
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811
COVID-19 PCR Test Results in Asymptomatic Pregnants
NCT04410939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregnant women with abnormal labs
Mothers who have abnormal labs during pregnancy with abnormal coagulation profile
labs
A group of questions to women regarding Corona with laboratory finding suggestive of covid 19 and coagulopathy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
labs
A group of questions to women regarding Corona with laboratory finding suggestive of covid 19 and coagulopathy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
42 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aljazeera Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Alalfy
Researcher at national research center, egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aljazeera( Al Gazeera) hospital
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Knowledge about covid 19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.